vs
CARRIAGE SERVICES INC（CSV）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是CARRIAGE SERVICES INC的1.6倍（$168.4M vs $105.5M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 8.0%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 1.0%）
怡和Cycle & Carriage有限公司是怡和集团在东南亚的投资控股公司，目前该集团持有其75%的股份，是怡和集团在东南亚区域开展资本布局与投资业务的核心平台。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
CSV vs ESPR — 直观对比
营收规模更大
ESPR
是对方的1.6倍
$105.5M
营收增速更快
ESPR
高出135.8%
8.0%
两年增速更快
ESPR
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.5M | $168.4M |
| 净利润 | $12.3M | — |
| 毛利率 | 34.8% | — |
| 营业利润率 | 23.3% | 50.6% |
| 净利率 | 11.6% | — |
| 营收同比 | 8.0% | 143.7% |
| 净利润同比 | 24.5% | — |
| 每股收益（稀释后） | $0.76 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSVESPR
| Q4 25 | $105.5M | $168.4M | ||
| Q3 25 | $102.7M | $87.3M | ||
| Q2 25 | $102.1M | $82.4M | ||
| Q1 25 | $107.1M | $65.0M | ||
| Q4 24 | $97.7M | $69.1M | ||
| Q3 24 | $100.7M | $51.6M | ||
| Q2 24 | $102.3M | $73.8M | ||
| Q1 24 | $103.5M | $137.7M |
净利润CSVESPR
| Q4 25 | $12.3M | — | ||
| Q3 25 | $6.6M | $-31.3M | ||
| Q2 25 | $11.7M | $-12.7M | ||
| Q1 25 | $20.9M | $-40.5M | ||
| Q4 24 | $9.9M | — | ||
| Q3 24 | $9.9M | $-29.5M | ||
| Q2 24 | $6.3M | $-61.9M | ||
| Q1 24 | $7.0M | $61.0M |
毛利率CSVESPR
| Q4 25 | 34.8% | — | ||
| Q3 25 | 35.3% | — | ||
| Q2 25 | 35.2% | — | ||
| Q1 25 | 35.3% | — | ||
| Q4 24 | 34.4% | — | ||
| Q3 24 | 35.2% | — | ||
| Q2 24 | 36.2% | — | ||
| Q1 24 | 36.0% | — |
营业利润率CSVESPR
| Q4 25 | 23.3% | 50.6% | ||
| Q3 25 | 17.0% | -11.4% | ||
| Q2 25 | 23.5% | 8.6% | ||
| Q1 25 | 29.5% | -34.0% | ||
| Q4 24 | 21.6% | -6.4% | ||
| Q3 24 | 22.7% | -31.0% | ||
| Q2 24 | 18.0% | 3.5% | ||
| Q1 24 | 18.8% | 52.5% |
净利率CSVESPR
| Q4 25 | 11.6% | — | ||
| Q3 25 | 6.4% | -35.9% | ||
| Q2 25 | 11.5% | -15.4% | ||
| Q1 25 | 19.5% | -62.2% | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | 9.8% | -57.2% | ||
| Q2 24 | 6.1% | -83.9% | ||
| Q1 24 | 6.7% | 44.3% |
每股收益（稀释后）CSVESPR
| Q4 25 | $0.76 | $0.32 | ||
| Q3 25 | $0.41 | $-0.16 | ||
| Q2 25 | $0.74 | $-0.06 | ||
| Q1 25 | $1.34 | $-0.21 | ||
| Q4 24 | $0.62 | $-0.14 | ||
| Q3 24 | $0.63 | $-0.15 | ||
| Q2 24 | $0.40 | $-0.33 | ||
| Q1 24 | $0.45 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7M | $167.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $254.8M | $-302.0M |
| 总资产 | $1.3B | $465.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CSVESPR
| Q4 25 | $1.7M | $167.9M | ||
| Q3 25 | $1.2M | $92.4M | ||
| Q2 25 | $1.4M | $86.1M | ||
| Q1 25 | $4.6M | $114.6M | ||
| Q4 24 | $1.2M | $144.8M | ||
| Q3 24 | $1.3M | $144.7M | ||
| Q2 24 | $1.5M | $189.3M | ||
| Q1 24 | $1.7M | $226.6M |
股东权益CSVESPR
| Q4 25 | $254.8M | $-302.0M | ||
| Q3 25 | $242.1M | $-451.4M | ||
| Q2 25 | $235.4M | $-433.5M | ||
| Q1 25 | $223.1M | $-426.2M | ||
| Q4 24 | $208.6M | $-388.7M | ||
| Q3 24 | $198.1M | $-370.2M | ||
| Q2 24 | $187.9M | $-344.2M | ||
| Q1 24 | $179.6M | $-294.3M |
总资产CSVESPR
| Q4 25 | $1.3B | $465.9M | ||
| Q3 25 | $1.3B | $364.0M | ||
| Q2 25 | $1.3B | $347.1M | ||
| Q1 25 | $1.3B | $324.0M | ||
| Q4 24 | $1.3B | $343.8M | ||
| Q3 24 | $1.3B | $314.1M | ||
| Q2 24 | $1.3B | $352.3M | ||
| Q1 24 | $1.3B | $373.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.1M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | $6.2M | — |
| 自由现金流率自由现金流/营收 | 5.9% | — |
| 资本支出强度资本支出/营收 | 7.5% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.15× | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势，按日历期对齐
经营现金流CSVESPR
| Q4 25 | $14.1M | $45.2M | ||
| Q3 25 | $24.7M | $-4.3M | ||
| Q2 25 | $8.1M | $-31.4M | ||
| Q1 25 | $13.8M | $-22.6M | ||
| Q4 24 | $9.3M | $-35.0M | ||
| Q3 24 | $20.9M | $-35.3M | ||
| Q2 24 | $2.2M | $-7.2M | ||
| Q1 24 | $19.7M | $53.8M |
自由现金流CSVESPR
| Q4 25 | $6.2M | — | ||
| Q3 25 | $18.0M | — | ||
| Q2 25 | $5.2M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | $16.2M | $-35.5M | ||
| Q2 24 | $-1.4M | $-7.3M | ||
| Q1 24 | $16.2M | $53.8M |
自由现金流率CSVESPR
| Q4 25 | 5.9% | — | ||
| Q3 25 | 17.5% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 16.1% | -68.7% | ||
| Q2 24 | -1.4% | -9.9% | ||
| Q1 24 | 15.6% | 39.0% |
资本支出强度CSVESPR
| Q4 25 | 7.5% | 0.0% | ||
| Q3 25 | 6.5% | 0.0% | ||
| Q2 25 | 2.8% | 0.0% | ||
| Q1 25 | 3.0% | 0.0% | ||
| Q4 24 | 4.5% | 0.0% | ||
| Q3 24 | 4.6% | 0.3% | ||
| Q2 24 | 3.5% | 0.1% | ||
| Q1 24 | 3.4% | 0.1% |
现金转化率CSVESPR
| Q4 25 | 1.15× | — | ||
| Q3 25 | 3.76× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 2.83× | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
